It has been widely studied that extracellular HMGB1 induced tumor progression through binding RAGE and TLRs and then activated its downstream signaling pathways (Angelopoulou et al., 2016; Wang et al., 2015). The gene discussed is HMGB1; the disease is neoplasm.